In an orthotopic murine colon cancer model, treatment with cetuximab alone increased the tumor volume and lymph node metastases, indicating that KRAS mutant CRC cells exhibit resistance to cetuximab. The gene discussed is KRAS; the disease is malignant colon neoplasm.